Biovail gets FDA okay for anti-depression tablet
‘Biovail Corp. said on Wednesday it received U.S. Food and Drug Administration approval for its orally disintegrating tablet formulation of citalopram hydrobromide to treat depression.
Biovail, a specialty pharmaceutical company, said it is considering a number of commercialization options for the product.’
Read more at Biovail gets FDA okay for anti-depression tablet